PATENT CLAIM ANALYSIS

Application Number: 16184270
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "139100"]

Abstract:
Broadly neutralizing interferon-α and interferon-ω antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are usefule in the treatment of diseases associated with increased production of IFNα and IFNω.

Claim (Index 13):
A pharmaceutical composition comprising the antibody of  claim 1  and a pharmaceutically accepted carrier.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14208861', '15707317', '14745939', '12551250', '14902409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6850435737425913
- 35 USC 102 Novelty (BERT): 0.5511819480994687
- Combined Prediction Score: 0.671657411178279
- Mean Citation Score: 300.085278
- Max Citation Score: 397.9143
- Similarity Product: 353.1237484784781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test